MAPP BIOPHARMACEUTICAL, INC.
MAPP BIOPHARMACEUTICAL, INC. has won 18 federal awards worth $240.2M in total across 2 agencies, with a median award of $61K. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.
Recent awards
| Title | Agency | Value | Date |
|---|---|---|---|
| PROCUREMENT OF HUMAN DERIVED MONOCLONAL ANTIBODIES AND ANTIGENS | Department Of Defense | $21K | 2026-02-06 |
| HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS | Department Of Defense | $61K | 2025-09-16 |
| THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (M | Department Of Health And Human Services | $110.9M | 2022-09-28 |
| PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES | Department Of Health And Human Services | $134.8M | 2022-09-27 |
| BASE YEAR FOR MACV CONTRACT GENERATES MACV IGG2 | Department Of Defense | $768K | 2021-09-24 |
Questions
How many federal contracts has MAPP BIOPHARMACEUTICAL, INC. won?
18 awards on record, worth $240.2M in total across 2 agencies. The median award is $61K.
Which agencies buy from MAPP BIOPHARMACEUTICAL, INC.?
Mostly Department Of Health And Human Services, Department Of Defense.
Is MAPP BIOPHARMACEUTICAL, INC. a competitor worth watching?
That depends on your category. This page lists the agencies they win from and their recent awards, so you can see whether they are active in the lanes you bid. AwardCast forecasts the closing price for a specific open solicitation, which is the number that matters when you are bidding against them.
Agencies they win from
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
$49 per report. No subscription, no account needed to see pricing.